Besnoitia besnoiti is an apicomplexan parasite responsible for bovine besnoitiosis, a disease with a high prevalence in tropical and subtropical regions and re-emerging in Europe. Despite the great economical losses associated with besnoitiosis, this disease has been underestimated and poorly studied, and neither an effective therapy nor an efficacious vaccine is available. Protein disulfide isomerase (PDI) is an essential enzyme for the acquisition of the correct three-dimensional structure of proteins. Current evidence suggests that in Neospora caninum and Toxoplasma gondii, which are closely related to B. besnoiti, PDI play an important role in host cell invasion, is a relevant target for the host immune response, and represents a promising drug target and/or vaccine candidate. In this work, we present the nucleotide sequence of the B. besnoiti PDI gene. BbPDI belongs to the thioredoxin-like superfamily (cluster 00388) and is included in the PDI_a family (cluster defined cd02961) and the PDI_a_PDI_a 0 _c subfamily (cd02995). A 3D theoretical model was built by comparative homology using Swiss-Model server, using as a template the crystallographic deduced model of Tapasin-ERp57 (PDB code 3F8U chain C). Analysis of the phylogenetic tree for PDI within the phylum apicomplexa reinforces the close relationship among B. besnoiti, N. caninum and T. gondii. When subjected to a PDI-assay based on the polymerisation of reduced insulin, recombinant BbPDI expressed in E. coli exhibited enzymatic activity, which was inhibited by bacitracin. Antiserum directed against recombinant BbPDI reacted with PDI in Western blots and by immunofluorescence with B. besnoiti tachyzoites and bradyzoites.
Introduction
Besnoitia besnoiti is a cyst-forming apicomplexan parasite of cattle with high veterinary relevance in many tropical and subtropical regions, with particular emphasis for sub-Saharan Africa (Bigalke and Prozesky, 2004) . In Europe, besnoitiosis has been recently reported in Portugal (Cortes et al., 2005 (Cortes et al., , 2006a , Spain (Castillo et al., 2009; Fernandez-Garcia et al., 2010; Irigoien et al., 2000) , France (Alzieu et al., 2007; Bourdeau et al., 2004; Lienard et al., 2010) , Italy (Agosti et al., 1994; Gollnick et al., 2010) and Germany (Mehlhorn et al., 2009; Schares et al., 2009 ). There is no treatment against this infection despite the efforts to identify and develop effective agents (Cortes et al., 2007; Shkap et al., 1987) . Live-attenuated vaccines have been used in Israel and South Africa (Basson et al., 1970 ) but they do not prevent subclinical infection and their use is geographically limited. Therefore, there is an urgent need for studying potential drug targets and vaccine candidates. Protein disulfide isomerase (PDI) is a key enzyme that enables proteins to acquire their correct threedimensional structure (Appenzeller-Herzog and Ellgaard, 2008; Hatahet et al., 2009; Wilkinson and Gilbert, 2004) . This enzyme, one of the most abundant in the endoplasmic reticulum (ER) and classically described as an ER-resident protein (Lambert and Freedman, 1985) , is a member of the thioredoxin superfamily (Ferrari and Soling, 1999) and consists of two homologous catalytic domains, a and a 0 , comprising each an active site with a CxxC motif, separated by two homologous non-catalytic domains, b and b 0 , and a highly acidic C-terminal extension c (Byrne et al., 2009; Edman et al., 1985; Kemmink et al., 1999; Kozlov et al., 2010) . PDI catalyses disulfide formation and the rearrangement of incorrect disulfide pairing during the oxidative protein folding process (Schwaller et al., 2003; Wilkinson and Gilbert, 2004) . proteins can lose their functionality and accumulate as large, insoluble aggregates that might interfere with cell viability (Wilkinson and Gilbert, 2004) . Current evidence suggests that PDIs are also involved in a wide range of other biological functions in many cellular compartments including the cell surface, where they may participate in the reducing exterior environment and/or may be involved in cell adhesion (Turano et al., 2002) . Parasite PDI-like enzymes were identified in Neospora caninum (Naguleswaran et al., 2005) , Toxoplasma gondii (Meek et al., 2002a,b) , Theileria parva (Ebel et al., 2002) , different Leishmania species (Hong and Soong, 2008; Ben et al., 2002; Padilla et al., 2003) , Cryptosporidium parvum (Blunt et al., 1996) and several species of Plasmodium (Florent et al., 2000; Mahajan et al., 2006; Mouray et al., 2007; Novo et al., 2009) . T. gondii and N. caninum, both closely related to B. besnoiti (Ellis et al., 2000) , have been shown to express highly homologous molecules, which could indicate that PDI plays a key role in the biology of neosporosis and toxoplasmosis (Ma et al., 2009; Meek et al., 2002a; Naguleswaran et al., 2005) . In this way, the important role of PDI in these two species and presumably in other apicomplexan parasites as well, might not allow for the accumulation of a large number of mutations in the protein sequence, rendering this molecule an interesting drug target. In fact, bacitracin and anti-PDI antibodies are effective at inhibiting the enzymatic activity of PDI in CHO cells (Mandel et al., 1993) , and allowed the demonstration of the fundamental role of PDI in N. caninum host cell invasion (Naguleswaran et al., 2005) . Furthermore, T. gondii PDI is targeted by mucosal IgA in humans (Meek et al., 2002a) and N. caninum PDI by IgA in cattle (Liao et al., 2006) , suggesting that PDI specific antibodies may be involved in the host defence against these parasites. In addition, the analysis of N. caninum antigenic proteins identified PDI as one of the immunodominant proteins associated with the processes of invasion, proliferation and egress of apicomplexan parasites (Shin et al., 2004 (Shin et al., , 2005 . The inhibitory effect of N. caninum PDI antiserum on the growth of this parasite was also demonstrated (Liao et al., 2006) . Recently, intranasal vaccination of mice with recombinant N. caninum PDI conferred 90% protection against disease and significantly reduced the cerebral parasite burden and the numbers of viable (live) tachyzoites in brain tissue (Debache et al., 2010) . All the evidence obtained so far points towards the importance of PDI in the host immune response and cell invasion process, and prompted us to characterize this molecule in B. besnoiti.
Materials and methods

Tissue culture and parasite purification
The B. besnoiti Bb1Evora03 strain was maintained by serial passages in confluent monolayers of Vero cells grown in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 20 mM HEPES pH 7.2-7.5, amphotericin B (250 lg/ml), 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 lg/ml), as previously described (Cortes et al., 2006b; Reis et al., 2006) . For parasite purification, freshly egressed tachyzoites were collected from the cell cultures supernatants, passed three times through a 25 G needle, were washed three times with PBS, and passed through PD10 columns according to the manufacturer's instructions (GE Healthcare). Bradyzoites were obtained from cysts in skin biopsies by mechanical disruption with an 18 G syringe needle and liberated parasites were washed and purified as above.
B. besnoiti PDI-gene sequence
B. besnoiti tachyzoites were purified from in vitro cultures, and genomic DNA was isolated using DNeasy Blood and Tissue Kit (Qiagen). Primers for the initial PCR amplifications were designed based on conserved regions of the aligned PDI nucleotide sequences from N. caninum (AY751081) and T. gondii (AJ312317).
PCR amplification was carried out in a 20 ll PCR mixture (1Â reaction buffer, 1 U of Taq DNA polymerase (Fermentas), 10 pmol of each primer, and 0.2 mM dNTP's), using B. besnoiti genomic DNA, primers PDIBesF2 (5 0 -GAGTGGATCGAGAAGATG-3 0 ) and PDIBesR2 (5 0 -GTGCCGTCCATCTTGGCAACA-3 0 ), and running 30 cycles (90°C for 30 s, 55°C for 1 min, 72°C for 1 min 15 s). PCR products were cloned in the pTZ57R/T vector (Fermentas), and sequenced in both directions by dideoxy-chain termination method (Sanger et al., 1977) . Primers for genome walking were designed based on the sequence obtained.
Genome walking libraries were generated and amplifications were carried out according to the manufacturer's instructions (Clontech, USA). 2.5 lg of genomic DNA was digested separately with AluI, HaeIII, HpaI or SmaI. Subsequently, the GenomeWalker adaptors were ligated to the DNA. PCR amplification of DNA fragments from genomic libraries was carried out using Taq DNA polymerase (Fermentas) and gene-specific primers PDIBesGWF1
. After the first genome walking, the products were cloned and sequenced and a second round of amplification was done with primers PDIBesGWR3 (5 0 -CGAGACATGCTGCTTTTGGAGGCCGACCAA-3 0 ) and PDI BesGWR4 (5 0 -GAAGCGACGCTGTCTGGAGACGTTCTGCAA-3 0 ). All clones were again sequenced in both directions, as above.
Production of recombinant B. besnoiti PDI (recBbPDI)
2.3.1. Cloning and sequencing of B. besnoiti PDI cDNA For cDNA synthesis, B. besnoiti tachyzoites were purified from in vitro cultures and total RNA was extracted (High Pure RNA Isolation Kit -Roche). RNA obtained from 10 8 tachyzoites was reverse transcribed by a two-step RT-PCR procedure (First Strand cDNA Synthesis Kit -Fermentas) for the production of cDNA. The PDI ORF was PCR-amplified using the forward primer PDIBesEX1 (5 0 -gaatccATGCGGGCTGGGGTCTGCTACCT-3 0 ) and the reverse primer PDIBesEX2 (5 0 -gctcgagTTACAATTCCTCGCCCTTGTCGTCCT-3 0 ), that contain EcoRI and XhoI sites respectively, and cDNA as template. Amplification was carried out using the conditions described above and performing 30 cycles (90°C for 30 s, 60°C for 1 min, 72°C for 1 min 15 s). PCR products were cloned into the pTZ57R/T vector (Fermentas), and sequenced.
Plasmid construction and expression
Full-length B. besnoiti PDI cDNA was released from pTZ57R-PDI by restriction-reactions with EcoRI and XhoI, subcloned into pGEX-6P-1 expression vector hydrolysed with the same enzymes, and sequenced for confirmation. Production and purification of recombinant glutathione S-transferase (GST) fusion protein was conducted according to the manufacturer's recommendation (GE Healthcare). Briefly, the pGEX-6P-PDI construct was transformed into E. coli BL21 cells, cultures were grown in liquid broth and induced when ABS 600 nm %0.8 for 2 h with 1 mM IPTG. The cell pellet was collected and lysis was performed by sonication. The recombinant B. besnoiti PDI (recBbPDI) was purified from the lysate using Glutathione Sepharose 4B and following the brand indications with the exception that 0.1% Triton X-100 was used in binding and washing steps. Protein quantification was performed using a NanoDrop 2000 spectrophotometer assuming an extinction coefficient of 93000 M À1 cm À1 and a molecular weight of 81 kDa.
Determination of the reductase activity of recBbPDI and its inhibition by bacitracin
RecBbPDI activity was measured by a turbidimetric assay based on the polymerization of reduced insulin (Lundstrom and Holmgren, 1990) as adapted by Smith et al. (2004) . Commercial bovine PDI (Sigma) was used as a control. Briefly, the assay was performed in 96-well microtiter plates and all solutions were made with assay buffer: 100 mM potassium phosphate, 2 mM EDTA, pH 7. Bacitracin, at concentrations ranging from 0.5 mM to 4 mM, or assay buffer (5 lL) were added to respective wells; the reaction solution was made by mixing 70 lL assay buffer with 10 lL of insulin (1.6 mM) and the enzymes or buffer (blank); 75 lL of reaction solution were added to each well and the reaction was started with 20 lL of 5 mM DTT. Absorbance at 650 nm was read in a SECTRAmax Ò 340 pc microplate spectrophotometer over 60 min every 5 min. Enzyme activity was calculated from the increase of turbidity over time ((ABS 650 at each time point -ABS 650 at time zero) enzyme -(ABS 650 at each time point -ABS 650 at time zero) blank ).
Antiserum production
One mouse was immunized intraperitoneally three times in intervals of three weeks, with approximately 10 lg of recBbPDI emulsified in Freund's incomplete adjuvant (MP Biomedicals, Inc.). The animal had free access to food and water and was housed and managed according to the applicable National and EU regulations. Four days after the last injection the mouse was bled and the specific anti-recBbPDI antibody titre determined by enzyme-linked immunosorbent assay (ELISA). Briefly, coating was performed with 0.1 lg/well of recBbPDI and alkaline phosphatase-conjugated secondary antibodies were used with p-nitrophenylphosphate (Sigma) (1 mg mL À1 ) in 100 mM glycine containing 1 mM MgCl 2 and 1 mM ZnCl 2 , pH 10.4 as enzyme substrate. The plate was incubated 30 min in the dark at room temperature and the reaction stopped by the addition of 50 lL 3 N NaOH. Absorbance was read at 405 nm in a TIM 200 Inter Med plate reader.
Western blotting
Protein samples were prepared from purified tachyzoites or bradyzoites. The cellular pellet (10 8 parasites) was resuspended in Laemmli sample buffer (BioRad) and heated for 5 min at 95°C. Proteins were separated by SDS-PAGE (12.5%) under reducing conditions and blotted onto nitrocellulose (Millipore) at 100 V for 1 h in Tris-glycine buffer with 20% (v/v) methanol. The membranes were blocked overnight at 4°C with 1% fish gelatin (Sigma) and probed with mouse anti-recBbPDI followed by incubation with alkaline phosphatase-conjugated goat anti-mouse-IgG secondary antibody (Sigma) diluted 1:5000. The final enzyme reaction was developed using the BCIP/NBT kit (Bio-Rad).
Immunofluorescence
Purified tachyzoites or bradyzoites were allowed to adhere to poly-L-lysine-coated microscopy coverslips for 30 min, and were fixed for 10 min with cold (À20°C) methanol. Parasites were then probed with mouse anti-recBbPDI serum and FITC-conjugated anti-mouse antibodies (Invitrogen). To visualize the entire cells, parasites were simultaneously probed with rabbit anti-B. besnoiti (Cortes et al., 2006b ) and TRITC-conjugated anti-rabbit antibodies (Invitrogen). All these sera were used at 1:500 dilutions. DNA was stained with DAPI (1 lg mL À1 ; Sigma) for 2 min and the slides were mounted with Mowiol (Calbiochem) and examined under a UV light microscope.
Database search and biocomputing approaches
Similarity searches on the Protein databank were done using the Blast search program (Altschul et al., 1990) . Alignment between two protein amino acid sequences was done using SIM (<http://expasy.org/tools/sim-prot.html>) (Huang and Miller, 1991) . Multiple sequence alignment of PDI amino acid sequences was performed using MEGA 4 and ClustalW (Kumar et al., 2008) . Search for BbPDI neighbors and phylogenic tree construction were performed using the web server phylogeny.fr (<http://www.phylogeny.fr>) (Dereeper et al., 2008) . Pattern search was performed using ScanProsite (<http://expasy.org/prosite/>) (Gattiker et al., 2002) and Superfamily 1.69 version (<http://supfam.org/SUPER-FAMILY/>) (Gough et al., 2001 ).
Comparative modelling and model validation
A theoretical three-dimensional model for PDI from B. besnoiti (BbPDI) was constructed by comparative modelling by the SwissModel server v. 3.7 (Arnold et al., 2006; Kiefer et al., 2009; Peitsch, 1996) (<http://swissmodel.expasy.org/>) using as template the heterodimer Tapasin-ERp57 crystallographic deduced model (Dong et al., 2009 ) (PDB code: 3F8U chain C). Superimposition of models and calculation of the root mean square values (RMS) between the model and modelling template using the Carbon alpha fitting, were made by Swiss-Pdb Viewer v. 3.7 (Guex and Peitsch, 1997) . RasMol v. 2.6 (Sayle and Milner-White, 1995) and SwissPdb Viewer v. 3.7 were used for visualization of models. Search for structurally similar proteins was done using Dali server v. 2.0 (<http://www.embl-ebi.ac.uk/dali/>) (Holm and Sander, 1993) . Model structure validation was performed by Procheck programs (Laskowski et al., 1993; Morris et al., 1992) . The substrate pocket was predicted using the WHAT IF program (<http://swift.cmbi.ru. nl/servers/html/index.html>) (Vriend, 1990) . The model was deposited in the PMDB (<http://mi.caspur.it/PMDB/>) (Castrignanò et al., 2006) under the identification number PM0075875. In this manuscript the BbPDI amino acid sequence numbering is based on ABF48402 entry.
Results and discussion
Molecular characterization of the gene coding for BbPDI
The gene sequence of B. besnoiti PDI was determined and deposited at GenBank under the accession No. DQ490130. The sequence analysis showed an ORF of 1416 nucleotides, comprising three exons, the first one spanning 164 bp, the second one 199 bp and a third one 1053 bp, which are separated by two introns of 343 bp and 97 bp respectively. The deduced amino acid sequence revealed a protein with 471 residues, presenting the characteristic catalytic thioredoxin motifs CxxC, and showing high amino acid conservation within the catalytic sites regions motif with other PDI entries in databases (Fig. 1) . A comparison of the BbPDI amino acid sequence with available PDI sequences from other species of the phylum apicomplexa revealed identity levels as follows: 88.2% for N. caninum (BAD67151) (NcPDI) and 87.7% for T. gondii (CAC28361) (TgPDI); between 48.1% and 48.2% for Plasmodium species, P. chabaudi (AAV36000) (PcPDI) P. yoelli (EAA17481) (PyP-DI), P. berghei (CAH95379) (PbPDI), P. falciparum (CAC15387) (PfPDI), and P. vivax (ABB72222) (PvPDI); 37.1% for C. parvum (AAB40710) (CpPDI); between 35.8% and 34.3% for Babesia and Theileria species, B. bovis (EDO05830) (BboPDI), B. caballi (BAE54313) (BcPDI), T. annulata (CAI75629) (TaPDI) and T. parva (EAN31157) (TpPDI).
As expected for members of the thioredoxin superfamily, two thioredoxin domains (PS51352) were identified in BbPDI. These are localized between amino acids 28-134 (a domain) and 351-459 (a 0 domain), and contain the thioredoxin family active site
between amino acids 48-66 (a domain) and amino acids 372-390 (a 0 domain). A putative thioltransferase domain is present between amino acids 223-335. The BbPDI a domain presents the characteristic CGHC eukaryotic active site motif, but there is a substitution of the histidine by a tyrosine in the a 0 domain active site motif (CGYC), similar to what was described for N. caninum (Naguleswaran et al., 2005) and T. gondii (Meek et al., 2002b) . The putative ER retention motif GEEL is present at C terminus of the amino acid sequence, diverging from the classical KDEL sequence found in eukaryotic ER-resident proteins (PS00014), but again in agreement with N. caninum (Naguleswaran et al., 2005) and T. gondii (Meek et al., 2002b) .
B. besnoiti PDI and its relationship to other members of the thioredoxin-like superfamily
BbPDI belongs to the thioredoxin like superfamily (cluster 00388) and is included in the PDI_a family (cluster defined cd02961) and the PDI_a_PDI_a 0 _c subfamily (cd02995). This subfamily includes ER-resident eukaryotic proteins involved in the 0 and a 0 , plus a highly acidic C-terminal extension c. Two domains contain a redox-active catalytic site (a and a 0 ), and the other (b and b 0 ) do not (Kemmink et al., 1995; Kozlov et al., 2010; Marchler-Bauer et al., 2009 ). Catalytic domains usually contain two cysteines in a CxxC active-site motif (Appenzeller-Herzog and Ellgaard, 2008) .
The search for protein neighbors through the web server phylogeny.fr on non redundant databases, identified orthologues in the Muridae family (Rattus norvegicus, Mus musculus), Hominidae family (Homo sapiens, Pan troglodytes), Bovidae family (Bos taurus), Nematoda phylum (Caenorhabitis elegans), in the Phaniasidae family (Gallus gallus), the Amphibia (Xenopus laevis) and Insecta class ( Culex quinquefasciatus), in the Branchistomidae family (Branchiostoma floridae); Viridiplantae ( Arabidopsis thaliana, Medicago sativa), in the phyla Apicomplexa (P. falciparum), Platyhelminthes ( Schistosoma mansoni), Dinoflagellata ( Perkinsus marinus) and in the Tetraodontidae family (Tetraodon nigroviridis).
No orthologue was detected in bacteria.
The multiple alignment between the a and a 0 domains of the PDI amino acid sequences from apicomplexan parasites (Fig. 2) showed that from the 20 residues around the active site motif, VlVkfYAPWCgHCKrmaPeY (B. besnoiti sequence) 12 are identical or their chemical properties are conserved. Also the P103-T104 and R120 residues (a domain) and P426 and R445 (a 0 domain) (B. besnoiti numbering) are conserved. The aligned residues to T104 in the a 0 domain are also conserved in all the apicomplexan PDIs except for the Sarcoscytidae in which the Threonine residue was changed to a Serine residue (similar chemical properties), S427 (B. besnoiti, T. gondii) and S429 for N. caninum. This residue conservation is similar to the one described for the human PDI family (Lappi et al., 2004) and indicates similar functional activities as reported for the equivalent residues in the human PDI family.
Analysis of the phylogenetic tree (Fig. 3) showed that at the first divergent node the Apicomplexa are divided into two branches, the first one comprising the Plasmodium (orthologue) and the Toxoplasma, Neospora, Besnoitia, Babesia and Theileria species homologues and the second one comprising the Cryptosporidiidae members. The first branch diverges again into one containing Toxoplasma, Besnoitia and Neospora PDI homologues and one containing the Babesia and Theileria homologues as expected. Orthologues from P. marinus are phylogenically closer to the Cryptosporidiidae than to B. besnoiti. Phylogenetically, B. besnoiti PDI is relatively divergent from bovine PDI from B. taurus, the target host for B. besnoiti infection, with an amino acid sequence identity of only 34% in 485 amino acids.
Analysis of an in silico model of B. besnoiti PDI
The catalytic sites exhibit a structure that is reminiscent for thioredoxin domains. Both a and a 0 domains have a double-wound alternating a/b fold, consisting of a 5-stranded b-sheet core, enclosed by 4 a-helices. The active site disulfide is located in a short segment at the N-terminus of helix 2, as described (Kemmink et al., 1996) , after a kink caused by the conserved Proline residue P64, (a domain) and P388 (a 0 domain). The view of the model (Fig. 4A) shows the four thioredoxin domains. Domains a, a 0 , b and b 0 are, as expected, presenting the five b-strands characteristic of the fold.
The stereochemical quality of the model, checked by Procheck program, showed that 95.6% of residues are in the core plus allowed regions of the Ramachandran plot. The model presents 99.3% of M/c bond lengths, 95.1% of M/c bond angles and 88.1% of planar groups within the expected limits and an overall G factor of À0.04. The structural alignment obtained from the superimposition of the model with the 3F8U_C template model showed a RMS of 0.33 Å on 407 Ca atoms and a RMS of 1.15 Å on 119 Ca atoms from the superimposition with the S. cerevisiae PDI crystallographic deduced model 2B5E. Search for structurally similar Fig. 3 . Mid-point rooting cladogram tree. Branch support values are presented. Accession numbers and parasite source were provided for PDI from Apicomplexa from the Plasmodiidae, Theileriidae, Babesiidae and Sarcoscystiidae families. The polypeptide sequences from the crystallographic deduced model used as a template for in silico modelling of BbPDI were also introduced. Orthologues from different species are shown. Some orthologues from M. musculus, P. troglodytes, P. marinus, C. quinquefasciatus, S. mansoni, B. floridae and X. laevis were omitted due to their similarities to other entries already included.
proteins using Dali reveals a very high structural similarity with the used template 3F8U chain C (Z score 42.6) against a Z score 27.1 for 2B5E chain A. The phylogenetical distance of the H. sapiens Tapasin-ERp57 (PDB code 3F8U_C) and the S. cerevisiae PDI (PDB code 2B5E_A) to B. besnoiti PDI is similar for both cases. As the comparative modelling is highly dependent on the degree of amino acid sequence identity, the discrepancies observed on the structural alignment could be due essentially to the low amino acid sequence identity, 28.7% in 456 amino acid overlap for 2B5E protein and 33.6% in 446 amino acid overlap for 3F8U_C sequence.
Analysis of catalytic domains
In each catalytic site, Cys residues are placed on a and a 0 domains face to face. On domain a, Cys residues are in a reduced state, in contrast to the oxidized state on a 0 domain, as occurs in Humicola insolens (Serve et al., 2010) . It was shown (Lappi et al., 2004) that the movement of the side chain of the Arg residues in human PDI, equivalent to B. besnoiti R120 and R445 residues, are used by the enzyme to maintain a high pK a value for the Cys residue, while allowing the reaction which requires a thiolate to proceed at an appropriate rate. Similar to what was described for human PDI, the side chains of R120 and R445 residues in BbPDI are also distant from the Cys residues of the active site suggesting an identical movement of the Arg side-chains during the catalytic mechanism.
Several studies showed that all domains of PDI act synergistically during catalysis. The experimental results from disulfidebond isomerase (DsbC) from E. coli (Banaszak et al., 2004; McCarthy et al., 2000) and Haemophilus influenza (Zhang et al., 2004) crystal structures, suggest hinge-flexibility within the proteins, which allows movements of the active sites, in order to accommodate the substrate in the cleft between the catalytic domains, and also differences in the orientation of the catalytic domains (Banaszak et al., 2004; McCarthy et al., 2000) . This flexibility, essentially due to the x-linker region between b 0 and a 0 domains, agrees with the experimental data (Nguyen et al., 2008; Wang et al., 2010) and is fundamental for interaction with folding substrates.
In the BbPDI model the distance of Cys residues of a and a 0 catalytic domains is approximately 35 Å. In addition to the predicted movement of the R120 and R445 residues, these facts agree with the hypothesis that substrate binding induces domain-movements, leading to a different orientation and distance between a and a 0 catalytic domains Cys residues.
Substrate pocket prediction on BbPDI by WHAT IF program (Fig. 4B) , detected one pocket comprising residues belonging to a, b and b 0 domains. The inclusion in the pocket of residues from b and b 0 domains is in agreement with the described participation of several domains in the binding activities of PDI suggesting that b and b 0 domains act to fix substrates for further catalytic chain action of the a and a 0 domains.
RecBbPDI catalytic activity and bacitracin inhibition
The activity of recombinant GST-tagged B. besnoiti PDI expressed in E. coli, was tested by following the aggregation of insulin at 650 nm, as a consequence of disulfide bond reduction (catalysed by PDI). RecBbPDI is functionally active and shows a dose dependent cross-linking activity in the range of 0.05 mM to 1.75 mM (Fig. 5A ). The profile of activity is similar to that observed for bovine PDI (bPDI) (Fig 5B) , although at lower enzyme concentrations recBbPDI exhibited higher activity levels and at higher concentrations (0.88 mM and 1.75 mM) recBbPDI activity levels are lower compared to bPDI.
BbPDI activities were sensitive to bacitracin, a classic PDI inhibitor, in a dose-dependent manner at enzyme concentrations ranging from 0.05 mM to 0.22 mM (Fig. 5C, D, E) . At higher enzyme concentrations, however, PDI activity was not inhibited in the range of bacitracin concentrations tested (0.5-4 mM) (data not shown). Bovine PDI used as control showed a dose dependent inhibition by bacitracin in the above-mentioned range (Fig. 5F ). In an attempt to understand differences in sensitivity of recBbPDI and bPDI to bacitracin in silico docking studies were performed. The data suggests that bacitracin makes hydrogen bonds within the substrate pocket residues Glu123 (a domain), Glu151 and Ser 152 (b domain) in the BbPDI model, and with Glu123, Glu153 and Ser154 in a B. taurus PDI model constructed by threading (data not shown). The comparative analysis suggests that bacitracin, due to a different orientation in the substrate pocket, interacts more extensively with the b 0 domain in bPDI than in BbPDI.
Western blotting analysis and immunolocalization of PDI
In Western blots of B. besnoiti tachyzoites and bradyzoites extracts, the anti-recBbPDI serum revealed a band of 53 kDa, as expected ( Fig. 6A and B) . The antiserum also reacted with a band of similar molecular mass in N. caninum and T. gondii tachyzoite extracts ( Fig. 6C and D) . This is not surprising, considering the high amino acid sequence homology of PDIs in the three species. Western blots of recBbPDI labeled with anti-recBbPDI antiserum revealed two bands, one corresponding to the GST-PDI-fusion protein ($81 kDa) and the other corresponding to free PDI devoid of the GST tag ($53 kDa) (Fig. 6E) .
The anti-recBbPDI serum, tested by immunofluorescence on B. besnoiti tachyzoites and bradyzoites smears, showed a scattered and uneven intracellular staining, with higher intensity in the perinuclear area, a pattern that is compatible with ER labeling (Fig. 7) . B. besnoiti PDI staining is similar in both parasite stages, but tachyzoites seems to show a more scattered distribution whereas bradyzoites a more spotted and condensed one with a clear empty intracellular PDI staining area, as shown in the merge image.
Conclusion
In conclusion, we showed that B. besnoiti expresses a PDI with 471 amino acid residues, presenting the two thioredoxin domains and the catalytic motif CxxC as expected for the members of the thioredoxin superfamily. Within the region of the catalytic sites there is a high amino acid sequence identity with PDIs from other apicomplexans, most notably with N. caninum and T. gondii. Phylogenetic analysis confirms that BbPDI belongs to a cluster comprising the PDIs from these two species. Using the SwissModel server it was possible to construct an in silico model by comparative modelling covering the four domains a, b, b 0 and a 0 . The results obtained by Procheck programs analysis, gave us confidence to use this model as a working hypothesis and the model presents the expected fold for all domains. As described in PDIs from other sources, the distance between catalytic domains and between Cys residues from each domain suggest the presence of the x region linking b 0 and a 0 domain, and agree with the hypothesis that substrate binding induces domain movements, leading to different orientations and distances between a and a 0 catalytic domains and Cys residues during the catalytic reaction. This confirms what has been found earlier for other PDI models.
Recombinant BbPDI shows a dose dependent catalytic activity and is inhibited by bacitracin. Western blotting results confirm the specificity of produced antiserum against PDI in B. besnoiti tachyzoite and bradyzoite extracts, and cross-reactive activity with PDIs from other apicomplexans confirms the close phylogenetic relationship between these species. Immunofluorescence-based localization studies show that this protein is largely associated with the ER in both tachyzoites and bradyzoites. These studies form the basis for future investigations directed towards the exploitation of BbPDI as a potential drug target or vaccine candidate. Fig. 6 . Western blot analysis using mouse anti-recBbPDI serum (1) and preimmune serum (2) applied (1:1000 dilution) onto: (A) B. besnoiti tachyzoite extract, (B) B. besnoiti bradyzoite extract, (C) N. caninum tachyzoite extract, (D) T. gondii tachyzoite extract and (E) GST-recBbPDI and recBbPDI. 
